Lombard Odier Asset Management (Switzerland)’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Sell
49,559
-3,600
-7% -$277K 0.14% 157
2025
Q4
$4.22M Sell
53,159
-66,533
-56% -$5.25M 0.18% 122
2025
Q3
$9.02M Buy
119,692
+26,116
+28% +$1.79M 0.41% 50
2025
Q2
$6.45M Buy
93,576
+1,552
+2% +$102K 0.33% 68
2025
Q1
$6.23M Buy
92,024
+44,240
+93% +$2.65M 0.36% 62
2024
Q4
$2.15M Sell
47,784
-3,740
-7% -$210K 0.16% 150
2024
Q3
$3.24M Sell
51,524
-35,116
-41% -$2.05M 0.27% 108
2024
Q2
$5.12M Sell
86,640
-1,708
-2% -$107K 0.52% 49
2024
Q1
$7.05M Buy
88,348
+56,240
+175% +$4.3M 0.5% 57
2023
Q4
$2.54M Buy
32,108
+20,692
+181% +$1.47M 0.34% 72
2023
Q3
$797K Sell
11,416
-1,080
-9% -$76.5K 0.13% 115
2023
Q2
$864K Sell
12,496
-99,638
-89% -$7.09M 0.12% 117
2023
Q1
$8.33M Sell
112,134
-98,354
-47% -$8.25M 0.73% 39
2022
Q4
$19.6M Sell
210,488
-32,800
-13% -$3.16M 1.57% 14
2022
Q3
$23.2M Sell
243,288
-51,881
-18% -$5.14M 1.97% 7
2022
Q2
$27.4M Sell
295,169
-41,298
-12% -$4.03M 2.32% 3
2022
Q1
$34.1M Buy
336,467
+326,473
+3,267% +$34.3M 2.67% 2
2021
Q4
$1.03M Sell
9,994
-312
-3% -$28.8K 0.07% 139
2021
Q3
$819K Buy
10,306
+863
+9% +$72.3K 0.05% 161
2021
Q2
$788K Buy
9,443
+725
+8% +$59.4K 0.04% 235
2021
Q1
$656K Buy
+8,718
New +$635K 0.04% 209
2020
Q4
Sell
-19,235
Closed -$1.12M 189
2020
Q3
$1.12M Sell
19,235
-1,379
-7% -$85.8K 0.12% 132
2020
Q2
$1.34M Sell
20,614
-4,562
-18% -$287K 0.21% 78
2020
Q1
$1.49M Buy
25,176
+19,459
+340% +$1.3M 0.2% 80
2019
Q4
$425K Hold
5,717
0.04% 257
2019
Q3
$361K Buy
+5,717
New +$339K 0.04% 275
2019
Q1
Sell
-93,356
Closed -$6.12M 376
2018
Q4
$6.12M Buy
93,356
+85,323
+1,062% +$6.37M 0.69% 41
2018
Q3
$632K Buy
+8,033
New +$574K 0.06% 219
2018
Q2
Sell
-40,091
Closed -$2.49M 330
2018
Q1
$2.49M Sell
40,091
-17,796
-31% -$1.28M 0.26% 68
2017
Q4
$4.2M Buy
57,887
+53,291
+1,160% +$3.87M 0.41% 54
2017
Q3
$374K Hold
4,596
0.04% 262
2017
Q2
$370K Hold
4,596
0.04% 276
2017
Q1
$361K Buy
+4,596
New +$367K 0.04% 284
2016
Q3
Sell
-200,596
Closed -$19.2M 145
2016
Q2
$19.2M Sell
200,596
-101,770
-34% -$10.1M 2.61% 13
2016
Q1
$31.4M Buy
302,366
+116,000
+62% +$11.3M 3.73% 2
2015
Q4
$18.2M Sell
186,366
-140,000
-43% -$13.7M 2.2% 13
2015
Q3
$31.5M Sell
326,366
-224,831
-41% -$23.6M 2.88% 6
2015
Q2
$57.8M Buy
551,197
+286,292
+108% +$29.3M 4.34% 2
2015
Q1
$27.4M Buy
264,905
+260,730
+6,245% +$26.4M 3.05% 6
2014
Q4
$404K Sell
4,175
-421,039
-99% -$37.1M 0.04% 257
2014
Q3
$33.9M Buy
425,214
+195,474
+85% +$15.4M 0.87% 17
2014
Q2
$17.3M Buy
+229,740
New +$17.4M 1.92% 9

Other funds holding CVS

Lombard Odier Asset Management (Switzerland)'s CVS Position: Q1 2026 in Review

Lombard Odier Asset Management (Switzerland) reduced its CVS Health (CVS) stake by 6.8% in Q1 2026, selling an estimated $277K and leaving 49,559 shares worth $3.56M. The position accounts for 0.14% of the portfolio, ranked #157.

Lombard Odier Asset Management (Switzerland) first reported a position in CVS in Q2 2014 and has held it in 42 quarters since. The position peaked at $57.8M in Q2 2015. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Lombard Odier Asset Management (Switzerland) held 49,559 shares of CVS Health worth $3.56M as of Q1 2026.
  • Lombard Odier Asset Management (Switzerland) sold 3,600 CVS Health shares in Q1 2026, an estimated $277K.
  • CVS Health made up 0.14% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #157 holding.
  • Lombard Odier Asset Management (Switzerland) first reported a position in CVS Health in Q2 2014 and has held it in 42 quarters since.
  • Lombard Odier Asset Management (Switzerland)'s CVS Health position peaked at $57.8M in Q2 2015.
  • 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.